anisms that maintain high pulmonary vascular resistance (PVR) and oppose vasodilation in the fetal lung are poorly understood. In fetal lambs, increased pulmonary artery pressure evokes a potent vasoconstriction, suggesting that a myogenic response contributes to high PVR in the fetus. In adult systemic circulations, the arachidonic acid metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) has been shown to modulate the myogenic response, but its role in the fetal lung is unknown. We hypothesized that acute increases in pulmonary artery pressure release 20-HETE, which causes vasoconstriction, or a myogenic response, in the fetal lung. To address this hypothesis, we studied the hemodynamic effects of , a specific inhibitor of 20-HETE production, on the pulmonary vasoconstriction caused by acute compression of the ductus arteriosus (DA) in chronically prepared fetal sheep. An inflatable vascular occluder around the DA was used to increase pulmonary artery pressure under three study conditions: control, after pretreatment with nitro-L-arginine (L-NA; to inhibit shear-stress vasodilation), and after combined treatment with both L-NA and a specific 20-HETE inhibitor, DDMS. We found that DA compression after L-NA treatment increased PVR by 44 Ϯ 12%. Although intrapulmonary DDMS infusion did not affect basal PVR, DDMS completely abolished the vasoconstrictor response to DA compression in the presence of L-NA (44 Ϯ 12% vs. 2 Ϯ 4% change in PVR, L-NA vs. L-NA ϩ DDMS, P Ͻ 0.05). We conclude that 20-HETE mediates the myogenic response in the fetal pulmonary circulation and speculate that pharmacological inhibition of 20-HETE might have a therapeutic role in neonatal conditions characterized by pulmonary hypertension. fetus; N-methylsufonyl-12,12-dibromododec-11-enamide; ductus arteriosus; 20-hydroxyeicosatetraenoic acid; nitric oxide synthase HIGH PULMONARY VASCULAR RESISTANCE (PVR) characterizes the fetal lung, resulting in very low pulmonary blood flow compared with the newborn or adult. At birth, in response to the release of several vasoactive agents, the lung undergoes a marked vasodilation, and pulmonary blood flow increases dramatically (2,11,14,31). The sustained nature of that vasodilator response stands in marked contrast to the fetal pulmonary circulation. Although the fetal lung is capable of vasodilating to a number of stimuli, including increased oxygen tension, alkalosis, and shear stress (1,3,(12)(13)(14)23), past studies have demonstrated that the vasodilator response is time limited. Despite ongoing exposure to the dilator stimulus, pulmonary blood flow gradually returns to normal, preserving the fetal phenotype marked by high PVR (1, 4).Our group (1, 28) recently reported that compression of the ductus arteriosus (DA) in the fetus, which diverts blood flow into the lung and simultaneously increases shear stress and pulmonary artery pressure (PAP), causes a biphasic response. Initially, PVR falls in response to increased shear stress. However, over 30 -60 min, a vasoconstrictor response to the increased i...